De la Rosa A - Search Results

1

A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.

MacDonald NJ, De la Rosa A, Benedict MA, Freije JM, Krutsch H, Steeg PS. MacDonald NJ, et al. Among authors: de la rosa a. J Biol Chem. 1993 Dec 5;268(34):25780-9. J Biol Chem. 1993. PMID: 8245015 Free article.

2

The potential roles of nm23 in cancer metastasis and cellular differentiation.

MacDonald NJ, de la Rosa A, Steeg PS. MacDonald NJ, et al. Among authors: de la rosa a. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1096-100. doi: 10.1016/0959-8049(95)00152-9. Eur J Cancer. 1995. PMID: 7576999 Review.

3

Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions.

de la Rosa A, Williams RL, Steeg PS. de la Rosa A, et al. Bioessays. 1995 Jan;17(1):53-62. doi: 10.1002/bies.950170111. Bioessays. 1995. PMID: 7702594 Review.

4

Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.

Walther MM, Anglard P, Gnarra J, Pozzatti R, Venzon D, de la Rosa A, MacDonald NJ, Steeg PS, Linehan WM. Walther MM, et al. Among authors: de la rosa a. J Urol. 1995 Jul;154(1):278-82. J Urol. 1995. PMID: 7776445

5

NM23 protein in neoplastic and nonneoplastic thyroid tissues.

Bertheau P, De La Rosa A, Steeg PS, Merino MJ. Bertheau P, et al. Among authors: de la rosa a. Am J Pathol. 1994 Jul;145(1):26-32. Am J Pathol. 1994. PMID: 8030752 Free PMC article.

6

Nm23 and breast cancer metastasis.

Steeg PS, de la Rosa A, Flatow U, MacDonald NJ, Benedict M, Leone A. Steeg PS, et al. Among authors: de la rosa a. Breast Cancer Res Treat. 1993;25(2):175-87. doi: 10.1007/BF00662142. Breast Cancer Res Treat. 1993. PMID: 8347849 Review.

7

Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.

de la Rosa A, Mikhak B, Steeg PS. de la Rosa A, et al. Arch Med Res. 1996 Autumn;27(3):395-401. Arch Med Res. 1996. PMID: 8854401

8

Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines.

Freije JM, Lawrence JA, Hollingshead MG, De la Rosa A, Narayanan V, Grever M, Sausville EA, Paull K, Steeg PS. Freije JM, et al. Among authors: de la rosa a. Nat Med. 1997 Apr;3(4):395-401. doi: 10.1038/nm0497-395. Nat Med. 1997. PMID: 9095172

9

MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.

Ouatas T, Clare SE, Hartsough MT, De La Rosa A, Steeg PS. Ouatas T, et al. Among authors: de la rosa a. Clin Exp Metastasis. 2002;19(1):35-42. doi: 10.1023/a:1013897022827. Clin Exp Metastasis. 2002. PMID: 11918081

10

Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Miele ME, De La Rosa A, Lee JH, Hicks DJ, Dennis JU, Steeg PS, Welch DR. Miele ME, et al. Among authors: de la rosa a. Clin Exp Metastasis. 1997 May;15(3):259-65. doi: 10.1023/a:1018473415458. Clin Exp Metastasis. 1997. PMID: 9174127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters